Morgan Stanley’s Treace Medical Concepts TMCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$294K	Buy	219,707 +10,984	+5%	+$21.9K	﹤0.01%	5704
2025 Q4	$511K	Sell	208,723 -551,586	-73%	-$2.4M	﹤0.01%	5505
2025 Q3	$5.1M	Sell	760,309 -259,120	-25%	-$1.69M	﹤0.01%	4132
2025 Q2	$5.99M	Sell	1,019,429 -512,714	-33%	-$3.34M	﹤0.01%	3909
2025 Q1	$12.9M	Sell	1,532,143 -609,323	-28%	-$5.48M	﹤0.01%	3110
2024 Q4	$15.9M	Sell	2,141,466 -1,132,591	-35%	-$7.58M	﹤0.01%	2978
2024 Q3	$19M	Buy	3,274,057 +443,027	+16%	+$2.85M	﹤0.01%	2848
2024 Q2	$18.8M	Sell	2,831,030 -461,038	-14%	-$3.72M	﹤0.01%	2737
2024 Q1	$43M	Sell	3,292,068 -2,943,400	-47%	-$39.2M	﹤0.01%	1897
2023 Q4	$79.5M	Buy	6,235,468 +6,021,962	+2,821%	+$60.8M	﹤0.01%	1962
2023 Q3	$2.8M	Sell	213,506 -231,152	-52%	-$4.23M	﹤0.01%	4154
2023 Q2	$11.4M	Buy	444,658 +27,944	+7%	+$721K	﹤0.01%	3044
2023 Q1	$10.5M	Buy	416,714 +233,531	+127%	+$5.48M	﹤0.01%	3097
2022 Q4	$4.21M	Buy	183,183 +94,320	+106%	+$2.17M	﹤0.01%	3900
2022 Q3	$1.96M	Buy	88,863 +49,698	+127%	+$961K	﹤0.01%	4442
2022 Q2	$560K	Buy	39,165 +18,878	+93%	+$318K	﹤0.01%	5357
2022 Q1	$384K	Sell	20,287 -23,998	-54%	-$466K	﹤0.01%	5565
2021 Q4	$826K	Buy	44,285 +40,675	+1,127%	+$839K	﹤0.01%	5212
2021 Q3	$97K	Buy	3,610 +1,703	+89%	+$46.9K	﹤0.01%	6401
2021 Q2	$59K	Buy	+1,907	New	+$60.7K	﹤0.01%	6603